Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical)
Reference8 articles.
1. The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years
2. Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
3. The efficacy and safety of antipsychotic medications in the treatment of psychosis in patients with Parkinson's disease;Divac;Behav Neurol,2016
4. Association of antipsychotic use with mortality risk in patients with Parkinson disease;Weintraub;JAMA Neurol,2016
5. Update on the treatment of Parkinson's disease psychosis: role of pimavanserin;Combs;Neuropsychiatr Dis Treat,2017
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Behavioral or neuropsychiatric symptoms of Alzheimer's disease: from psychopathology to pharmacological management;Arquivos de Neuro-Psiquiatria;2023-12
2. Advances in the treatment and management of frontotemporal dementia;Expert Review of Neurotherapeutics;2023-06-26
3. Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions;Neuropsychiatric Disease and Treatment;2023-05
4. Parkinson Disease Dementia Management: an Update of Current Evidence and Future Directions;Current Treatment Options in Neurology;2023-03-13
5. Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis;PLOS ONE;2023-01-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3